However, estimates of breast cancer risks to age 70 years of age derived from previous population based studies to date are much lower at 28–60% [4-6] for BRCA1, and lower still for BRCA2. It has been suggested that even these studies may overestimate the effect of the BRCA1/2 mutation alone [9]. The gene discussed is BRCA2; the disease is breast carcinoma.